In
Chinese market, there are mainly three categories of invitro diagnostic
reagents, biochemical diagnostic reagents, immune diagnostic reagents and
molecular diagnostic reagents, accounting for about 65% of invitro diagnostic
reagent market in total in 2012.
To Read The Complete Report with
TOC :
Global
invitro diagnostics market is mature and the concentration rate is high. The 8
major enterprises account for over 70% market share. In 2011, the market scale
of global invitro diagnostics reached USD 46 billion, among which developed
countries accounted for over 80%. Currently, emerging economic entities occupy
low proportions, while their growth rates are far ahead of that of mature
markets.
In
China, barriers to entry of this industry are not high and the concentration
rate is low. The majority of enterprises concentrate in the biochemical reagent
field, so the competition is mainly in the biochemical field. Both the supply
and demand of immune and molecular products are prosperous. In addition to
immune reagents, markets of other diagnostic reagents are mainly occupied by
Chinese domestic enterprises. Although China invitro diagnostic reagent
industry started late and its scale is limited, it grows rapidly. In 2012, the
market scale reached CNY 13.6 billion, among which immune diagnostic reagents,
biochemical diagnostic reagents and molecular diagnostic reagents ranked among
the top.
To Buy a Copy Of This Report:-
According
to the investigation of CRI, the production line utilization of various invitro
diagnostic reagent manufacturers is universally high. Therefore, CRI predicts
that the production capacity of the industry will expand in the future.
Furthermore, the development strategy of most enterprises is transversely
enriching product varieties and vertically developing towards the upstream and
downstream.
Contact:-
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment